2025-18897Notice

FDA Guides Flexible Drug Trial Designs for Efficiency

Published Date: 9/30/2025

Notice

Summary

The FDA just released a draft guide to help drug makers run smarter, more flexible clinical trials called adaptive designs. This new advice aims to make trials clearer and more reliable, helping companies prove their treatments work safely. If you’re in the drug development world, keep an eye out—this could speed up how trials are done and save money in the long run!

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
9/30/2025
12/1/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in